TMCnet News
POC Testing to Boost the Cardiac Biomarkers Market | TechnavioThe global cardiac biomarkers market is expected to grow at a CAGR of close to 13% during the forecast period, according to Technavio's latest market research. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171023006237/en/ 
Technavio has published a new report on the global cardiac biomarkers market from 2017-2021. (Graphic: Business Wire) In this market research report, Technavio covers the market outlook and growth prospects of the global cardiac biomarkers market for 2017-2021. The market is further categorized into four major product segments, comprising of troponin, BNP, CK-MB, and myoglobin. The troponin assay segment dominated the market accounting for close to 34% of the market share in 2016. "The global cardiac biomarkers market is growing at a significant pace owing to the rising incidence of cardiac diseases globally. The use of cardiac biomarkers during a patient examination in the emergency department helps to increase the chances of survival. Moreover, increasing use of cardiac biomarkers during point-of-care testing is one of the emerging trends which augurs well for the growth of the market during the forecast period," says Srinivas Sashidhar, a lead cardiovascular devices research expert from Technavio. Technavio's research analysts segment the global cardiac biomarkers market into the following regions:
Looking for more information on this market? Request a free sample report <> Technavio's sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.Cardiac biomarkers market in Americas The Americas contributes the highest market share in the global cardiac biomarkers market. The factors that attribute to the market growth are the increasing prevalence of cardiac diseases along with the introduction of new precise and accurate cardiac biomarkers. In North America, the US was the largest revenue contributor for global cardiac biomarkers market. Other countries in the Americas such as Canada, Brazil, and Argentina also contribute to the market share due to the high adoption rate among their population. This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. Cardiac biomarkers market in EMEA In EMEA, the major revenue contributors to the cardiac biomarkers market include countries such as the UK, Germany, Italy, Spain, and France. The increasing prevalence of diabetes and the rising awareness about the benefits of cardiac biomarkers are increasing their demand in EMEA. In addition, the increasing older population and rising number of products receiving regulatory approval are also driving the market growth. Top vendors such as Siemens (News - Alert), Abbott, and F. Hoffmann-La Roche are emphasizing on developing more accurate and specific products through rapid clinical trials in association with end-users such as hospitals and universities. These companies are also focusing on providing cost-effective products to the end-users for maintaining their position in the market. Cardiac biomarkers market in APAC In 2016, countries such as Japan, China, Australia, Korea, and India contributed toward the growth of the cardiac biomarkers market in APAC. Technological innovations, increasing older population, rise in cardiac diseases, and improvements in healthcare infrastructure are among the significant growth drivers of this market. "Growing awareness about POC testing for cardiac biomarkers among consumers is expected to contribute to the growth of the market during the forecast period. The other major factors influencing market growth are increasing rate of cardiac diseases and growing diabetic population in the region. Small and medium-sized vendors are expected to collaborate with leading players to penetrate untapped regions," says Srinivas. The top vendors in the global cardiac biomarkers market as highlighted in this market research analysis are:
Browse Related Reports:
About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. If you are interested in more information, please contact our media team at [email protected]. View source version on businesswire.com: http://www.businesswire.com/news/home/20171023006237/en/ |
